Bookmark

Add to MyYahoo RSS

HiTech Pharmacal Co News

News on HiTech Pharmacal Co (Ticker: HITK) continually updated from thousands of sources around the net.

Tuesday | Sys-Con Media

Repligen Corporation Set to Join the S&P SmallCap 600

S&P SmallCap 600 constituent Akorn Inc. is acquiring Hi-Tech Pharmacal Co. in a deal expected to be completed soon.

Comment?

Related Topix: Repligen, Biotech, Medicine, Healthcare Industry, Pharmaceuticals, Akorn, Financial Markets

Tuesday | InvestorIdeas.com

Small Cap Stocks to Watch: The Future of Diabetes Care

April 15, 2014 An article this month from Reuters Health involved a positive message for Americans at-risk for diabetes or suffering from the disease: out-of-pocket expenses for diabetes treatment has actually decreased, according to a study just released by the CDC.

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Pharmaceuticals, Healthcare Industry, Amityville, NY

Mon Apr 14, 2014

Business Wire

View Press Release

The unanimous vote in support of the transactions follows Akorn's agreement to a proposed consent order requiring divestiture of certain products as a condition to obtaining FTC approval.

Comment?

Related Topix: Biotech, Medicine, Akorn, Healthcare Industry, Pharmaceuticals, Marketing, Decatur, IL

Reuters

UPDATE 1-Akorn gets U.S. approval to buy Hi-Tech Pharmacal, with conditions

Generic drugmaker Akorn Enterprises Inc has won U.S. antitrust approval to buy rival Hi-Tech Pharmacal Inc on condition that it sell three generic prescription eye medications and two generic topical anesthetics, the Federal Trade Commission said on Monday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals, Watson Pharmaceuticals

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••